SELLAS Life Sciences Group (SLS) Institutional Ownership $1.22 -0.03 (-2.02%) (As of 11:20 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$7.21MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.69K Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024Virtu Financial LLC79,241$99K0.0%+24.1%0.113% 11/16/2024 Geode Capital Management LLC605,191$757K0.0%+17.1%0.941% 11/15/2024 Anson Funds Management LP793,835$992K0.0%N/A1.234% 11/15/2024 XTX Topco Ltd62,785$78K0.0%N/A0.098% 11/15/2024 State Street Corp174,529$218K0.0%+30.2%0.271% 8/9/2024 Renaissance Technologies LLC32,446$39K0.0%N/A0.056% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 5/20/2024Virtu Financial LLC39,429$40K0.0%-34.2%0.068% 5/14/2024 Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366% 4/26/2024 Opus Capital Group LLC200,600$203K0.0%+48.6%0.356% 2/13/2024 Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024 Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% 9/12/2023 Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% 5/11/2023 Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 1/18/2023 Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 2/14/2022 GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022 Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021 Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021 Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021 Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021 Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021 Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021 Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021 State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021 Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021 Northern Trust Corp24,605$273K0.0%+35.9%0.163% 8/13/2021 Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021 Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021 Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% 8/12/2021 Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021 Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, 10 institutional investors and hedge funds held shares of SELLAS Life Sciences Group. The most heavily invested institutionals were Highbridge Capital Management LLC ($2.58M), Anson Funds Management LP ($992K), Armistice Capital LLC ($869K), Geode Capital Management LLC ($757K), State Street Corp ($218K), Opus Capital Group LLC ($203K), and Virtu Financial LLC ($99K).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? Of the 10 institutional investors that purchased SELLAS Life Sciences Group stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Anson Funds Management LP ($5.63M), Highbridge Capital Management LLC ($1.81M), Armistice Capital LLC ($820K), Opus Capital Group LLC ($185.77K), Geode Capital Management LLC ($88.18K), XTX Topco Ltd ($62.79K), and State Street Corp ($40.50K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 8,706,141 shares in the last 24 months. This purchase volume represents approximately $9.89M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Virtu Financial LLC ($20.49K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 20,485 shares in the last 24 months. This volume of shares sold represents approximately $20.69K in transactions. Related Companies Q32 Bio Major Shareholders Kamada Major Shareholders biote Major Shareholders AC Immune Major Shareholders Cryoport Major Shareholders Jasper Therapeutics Major Shareholders Design Therapeutics Major Shareholders COMPASS Pathways Major Shareholders Sage Therapeutics Major Shareholders Kodiak Sciences Major Shareholders This page (NASDAQ:SLS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.